Bank of Montreal’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $80.4M | Buy |
889,022
+58,111
| +7% | +$4.87M | 0.03% | 445 |
|
|
2026
Q1 | $66.5M | Sell |
830,911
-54,301
| -6% | -$4.48M | 0.02% | 463 |
|
|
2025
Q4 | $76.3M | Buy |
885,212
+41,057
| +5% | +$3.37M | 0.03% | 434 |
|
|
2025
Q3 | $65.6M | Buy |
844,155
+159,257
| +23% | +$12.4M | 0.03% | 423 |
|
|
2025
Q2 | $53.6M | Sell |
684,898
-136,956
| -17% | -$10.2M | 0.03% | 416 |
|
|
2025
Q1 | $59.6M | Sell |
821,854
-96,016
| -10% | -$6.87M | 0.03% | 387 |
|
|
2024
Q4 | $67.9M | Sell |
917,870
-263,114
| -22% | -$18.4M | 0.03% | 379 |
|
|
2024
Q3 | $78.6M | Sell |
1,180,984
-46,215
| -4% | -$3.36M | 0.03% | 351 |
|
|
2024
Q2 | $113M | Buy |
1,227,199
+20,240
| +2% | +$1.79M | 0.03% | 268 |
|
|
2024
Q1 | $115M | Sell |
1,206,959
-90,717
| -7% | -$7.62M | 0.03% | 269 |
|
|
2023
Q4 | $99.6M | Buy |
1,297,676
+11,750
| +0.9% | +$818K | 0.03% | 298 |
|
|
2023
Q3 | $103M | Buy |
1,285,926
+5,086
| +0.4% | +$409K | 0.04% | 262 |
|
|
2023
Q2 | $121M | Buy |
1,280,840
+136,725
| +12% | +$11.9M | 0.04% | 224 |
|
|
2023
Q1 | $94.7M | Sell |
1,144,115
-75,310
| -6% | -$5.92M | 0.04% | 249 |
|
|
2022
Q4 | $91M | Buy |
1,219,425
+304,263
| +33% | +$23.4M | 0.04% | 258 |
|
|
2022
Q3 | $88.2K | Buy |
915,162
+29,047
| +3% | +$2.79M | 0.04% | 250 |
|
|
2022
Q2 | $89.5K | Sell |
886,115
-88,282
| -9% | -$9.14M | 0.04% | 266 |
|
|
2022
Q1 | $114M | Sell |
974,397
-16,493
| -2% | -$1.85M | 0.06% | 241 |
|
|
2021
Q4 | $130M | Sell |
990,890
-251,247
| -20% | -$29.3M | 0.07% | 213 |
|
|
2021
Q3 | $142M | Buy |
1,242,137
+149,516
| +14% | +$17.1M | 0.06% | 256 |
|
|
2021
Q2 | $113M | Buy |
1,092,621
+287,461
| +36% | +$27.1M | 0.06% | 282 |
|
|
2021
Q1 | $67.8M | Sell |
805,160
-84,871
| -10% | -$7.18M | 0.04% | 340 |
|
|
2020
Q4 | $79.5M | Buy |
890,031
+138,681
| +18% | +$11.5M | 0.05% | 297 |
|
|
2020
Q3 | $59M | Sell |
751,350
-231,995
| -24% | -$18.1M | 0.05% | 313 |
|
|
2020
Q2 | $67.1M | Sell |
983,345
-311,551
| -24% | -$22.1M | 0.06% | 266 |
|
|
2020
Q1 | $79.8M | Sell |
1,294,896
-154,521
| -11% | -$11.1M | 0.09% | 185 |
|
|
2019
Q4 | $113M | Buy |
1,449,417
+417,099
| +40% | +$32.6M | 0.08% | 208 |
|
|
2019
Q3 | $75.7M | Buy |
1,032,318
+220,119
| +27% | +$15.5M | 0.07% | 258 |
|
|
2019
Q2 | $50M | Buy |
812,199
+18,552
| +2% | +$1.12M | 0.04% | 369 |
|
|
2019
Q1 | $50.6M | Buy |
793,647
+46,818
| +6% | +$2.67M | 0.04% | 341 |
|
|
2018
Q4 | $38.1M | Sell |
746,829
-3,534
| -0.5% | -$179K | 0.04% | 390 |
|
|
2018
Q3 | $43.5M | Buy |
750,363
+221,961
| +42% | +$10.9M | 0.03% | 401 |
|
|
2018
Q2 | $25.6M | Sell |
528,402
-348,153
| -40% | -$16.3M | 0.02% | 535 |
|
|
2018
Q1 | $40.8M | Buy |
876,555
+168,831
| +24% | +$7.33M | 0.04% | 407 |
|
|
2017
Q4 | $26.6M | Buy |
707,724
+216,924
| +44% | +$7.96M | 0.02% | 526 |
|
|
2017
Q3 | $17.9M | Buy |
490,800
+11,460
| +2% | +$437K | 0.02% | 630 |
|
|
2017
Q2 | $18.9M | Sell |
479,340
-89,715
| -16% | -$3.27M | 0.02% | 610 |
|
|
2017
Q1 | $17.8M | Buy |
569,055
+136,575
| +32% | +$4.28M | 0.02% | 594 |
|
|
2016
Q4 | $11.9M | Sell |
432,480
-331,791
| -43% | -$10.8M | 0.01% | 738 |
|
|
2016
Q3 | $30.7M | Buy |
764,271
+150
| +0% | +$5.65K | 0.03% | 421 |
|
|
2016
Q2 | $25.4M | Sell |
764,121
-223,017
| -23% | -$7.63M | 0.03% | 465 |
|
|
2016
Q1 | $29M | Buy |
987,138
+203,379
| +26% | +$5.61M | 0.03% | 374 |
|
|
2015
Q4 | $20.6M | Sell |
783,759
-2,330,799
| -75% | -$60.5M | 0.02% | 471 |
|
|
2015
Q3 | $73.8M | Sell |
3,114,558
-434,394
| -12% | -$10.5M | 0.1% | 183 |
|
|
2015
Q2 | $84.2M | Sell |
3,548,952
-4,574,448
| -56% | -$103M | 0.1% | 193 |
|
|
2015
Q1 | $193M | Buy |
8,123,400
+4,910,808
| +153% | +$110M | 0.22% | 100 |
|
|
2014
Q4 | $68.2M | Buy |
3,212,592
+39,786
| +1% | +$799K | 0.08% | 218 |
|
|
2014
Q3 | $54M | Buy |
3,172,806
+2,763,744
| +676% | +$43.6M | 0.06% | 265 |
|
|
2014
Q2 | $5.85M | Buy |
409,062
+89,814
| +28% | +$1.22M | 0.01% | 1027 |
|
|
2014
Q1 | $3.95M | Buy |
319,248
+131,712
| +70% | +$1.52M | 0.01% | 1028 |
|
|
2013
Q4 | $2.06M | Buy |
187,536
+6,468
| +4% | +$72.9K | ﹤0.01% | 1181 |
|
|
2013
Q3 | $2.1M | Buy |
181,068
+29,874
| +20% | +$349K | ﹤0.01% | 1146 |
|
|
2013
Q2 | $1.69M | Buy |
+151,194
| New | +$1.79M | ﹤0.01% | 1171 |
|
Other funds holding EW
VCM
VPM
Bank of Montreal's EW Position: Q2 2026 in Review
Bank of Montreal increased its Edwards Lifesciences (EW) stake by 7% in Q2 2026, buying an estimated $4.87M and bringing the position to 889,022 shares worth $80.4M. The position accounts for 0.03% of the portfolio, ranked #445.
Bank of Montreal first reported a position in EW in Q2 2013 and has held it in 53 quarters since. The position peaked at $193M in Q1 2015. 1,096 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- Bank of Montreal held 889,022 shares of Edwards Lifesciences worth $80.4M as of Q2 2026.
- Bank of Montreal bought 58,111 Edwards Lifesciences shares in Q2 2026, an estimated $4.87M.
- Edwards Lifesciences made up 0.03% of Bank of Montreal's portfolio in Q2 2026, its #445 holding.
- Bank of Montreal first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 53 quarters since.
- Bank of Montreal's Edwards Lifesciences position peaked at $193M in Q1 2015.
- 1,096 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.